6-KThe Wire
Alpha Tau Medical Ltd. files 6-K
Filed Dec 2, 2025 · 8mo ago · Accession 0001213900-25-116980
Plain English
Alpha Tau Medical Ltd. announced it received FDA approval to initiate a trial for patients with locally recurrent prostate cancer. The company filed this announcement on December 2, 2025.
Filing details
- Company
- Alpha Tau Medical Ltd.
- Ticker
- DRTS
- CIK
- 1871321
- Form type
- 6-K
- Filing date
- Dec 2, 2025
- Report date
- Dec 2, 2025
- Document
- ea026791901-6k_alphatau.htm
- Size
- 23 KB